CS20AT04 / CoreStem 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CS20AT04 / CoreStem
NCT04835883: Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

Recruiting
2
10
RoW
CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)
Hanyang University Seoul Hospital, Corestem, Inc., Ministry of Health & Welfare, Korea
Systemic Lupus Erythematosus
11/21
01/26
NCT04522505: Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject With Lupus Nephritis

Completed
N/A
6
RoW
Corestemchemon, Inc., Hanyang University
Lupus Nephritis
02/24
07/24

Download Options